These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8024010)

  • 1. Stimulation of the nigrostriatal dopamine system produces hypertension and tachycardia in rats.
    Lin MT; Yang JJ
    Am J Physiol; 1994 Jun; 266(6 Pt 2):H2489-96. PubMed ID: 8024010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of the nigrostriatal dopamine system inhibits both heat production and heat loss mechanisms in rats.
    Lin MT; Ho MT; Young MS
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Nov; 346(5):504-10. PubMed ID: 1470222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMDA receptor blockade increases in vivo striatal dopamine synthesis and release in rats and mice with incomplete, dopamine-depleting, nigrostriatal lesions.
    Richard MG; Bennett JP
    J Neurochem; 1995 May; 64(5):2080-6. PubMed ID: 7722491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage.
    Zhang WQ; Tilson HA; Nanry KP; Hudson PM; Hong JS; Stachowiak MK
    Brain Res; 1988 Oct; 461(2):335-42. PubMed ID: 3141002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Ca2+ dependence and time course of somatodendritic dopamine release: substantia nigra versus striatum.
    Chen BT; Rice ME
    J Neurosci; 2001 Oct; 21(19):7841-7. PubMed ID: 11567075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nigrostriatal dopamine system mediates baroreflex sensitivity in rats.
    Lu SF; Young HJ; Lin MT
    Neurosci Lett; 1995 Apr; 190(1):17-20. PubMed ID: 7624045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine.
    Matsuura K; Makino H; Ogawa N
    Exp Neurol; 1997 Aug; 146(2):526-35. PubMed ID: 9270064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of electrical and chemical stimulation of the subthalamic nucleus on the release of striatal dopamine.
    Pazo JH; Höcht C; Barceló AC; Fillipini B; Lomastro MJ
    Synapse; 2010 Dec; 64(12):905-15. PubMed ID: 20939061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between asymmetries in striatal dopamine release and the direction of amphetamine-induced rotation during the first week following a unilateral 6-OHDA lesion of the substantia nigra.
    Robinson TE; Noordhoorn M; Chan EM; Mocsary Z; Camp DM; Whishaw IQ
    Synapse; 1994 May; 17(1):16-25. PubMed ID: 8042143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indirect presynaptic modulation of striatal dopamine release by GABA(B) receptors in the rat substantia nigra.
    Balon N; Kriem B; Weiss M; Rostain JC
    Neurosci Lett; 2002 May; 325(1):33-6. PubMed ID: 12023061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in SK channel expression in the basal ganglia after partial nigrostriatal dopamine lesions in rats: Functional consequences.
    Mourre C; Manrique C; Camon J; Aidi-Knani S; Deltheil T; Turle-Lorenzo N; Guiraudie-Capraz G; Amalric M
    Neuropharmacology; 2017 Feb; 113(Pt A):519-532. PubMed ID: 27825825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical detection of L-DOPA-derived dopamine within serotonergic fibers in the striatum and the substantia nigra pars reticulata in Parkinsonian model rats.
    Yamada H; Aimi Y; Nagatsu I; Taki K; Kudo M; Arai R
    Neurosci Res; 2007 Sep; 59(1):1-7. PubMed ID: 17586078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of nigrostriatal dopamine neurones by nicotine.
    Lichtensteiger W; Hefti F; Felix D; Huwyler T; Melamed E; Schlumpf M
    Neuropharmacology; 1982 Oct; 21(10):963-8. PubMed ID: 7145035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of electrically evoked dopamine release and reuptake in substantia nigra, ventral tegmental area, and striatum.
    Cragg S; Rice ME; Greenfield SA
    J Neurophysiol; 1997 Feb; 77(2):863-73. PubMed ID: 9065855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine, haloperidol, and the D4 antagonist PNU-101387G: in vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin release.
    Broderick PA; Piercey MF
    J Neural Transm (Vienna); 1998; 105(6-7):749-67. PubMed ID: 9826116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nigrostriatal cell firing action on the dopamine transporter.
    Rodriguez M; Gonzalez S; Morales I; Sabate M; Gonzalez-Hernandez T; Gonzalez-Mora JL
    Eur J Neurosci; 2007 May; 25(9):2755-65. PubMed ID: 17561841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substantia nigra 6-hydroxydopamine lesions alter dopaminergic synaptic markers in the nucleus basalis magnocellularis and striatum of rats.
    Geula C; Slevin JT
    Synapse; 1989; 4(3):248-53. PubMed ID: 2532792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrical stimulation of the nigrostriatal pathway after HA-966 block of triatal dopamine release.
    Van Valkenburg CF; Noach EL
    Eur J Pharmacol; 1978 Mar; 48(2):171-7. PubMed ID: 639847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.